Clinical Trial Update: Denosumab and Screw Fixation for Osteoporotic Compression Fracture [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial evaluating denosumab with screw fixation for osteoporotic compression fracture was withdrawn after Phase 2/3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporotic Compression Fracture

Drugs mentioned

• Denosumab (denosumab)

Snippet

Sponsor: Shenzhen People's Hospital | Conditions: Denosumab Allergy | Phase 2, Phase 3 | Status: WITHDRAWN